| Muna Tosnim Alam, DO | |
|
844 Washington Rd Ste 302, Westminster, MD 21157-6664 | |
| (410) 876-2003 | |
| (410) 848-3009 |
| Full Name | Muna Tosnim Alam |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 16 Years |
| Location | 844 Washington Rd Ste 302, Westminster, Maryland |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376895557 | NPI | - | NPPES |
| H90804 | Other | MD | STATE LICENSE |
| 585849600 | Medicaid | MD | |
| 03512012 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 266899 (New York) | Secondary |
| 207V00000X | Obstetrics & Gynecology | H0090804 (Maryland) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Womens Care Llc | 4880582741 | 248 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months ended December 31, 2009. The Company reported a net loss of $15,276,000, or $0.33 per basic share, compared to a loss of $459,000, or $0.01 per basic share, for the three months ended December 31, 2008.
Celgene International Sàrl (NASDAQ: CELG) today announced results from a subset analysis of the international phase III trial (AZA-001) demonstrating that the overall survival benefit observed in higher-risk MDS patients extended to patients with acute myeloid leukemia (AML).
Scientists at the Gladstone Institutes and the University of California, San Francisco have successfully converted human skin cells into fully-functional pancreatic cells. The new cells produced insulin in response to changes in glucose levels, and, when transplanted into mice, the cells protected the animals from developing diabetes in a mouse model of the disease.
A study comparing the aerobic bacterial bioburden associated with surgical scrub attire shows significantly greater contamination among home-laundered attire than scrubs laundered by the healthcare facility, scrubs sent out by the facility to a third-party company for laundering, or single-use/disposable scrubs.
"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.
› Verified 8 days ago
| Entity Name | Capital Womens Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679534069 PECOS PAC ID: 4880582741 Enrollment ID: O20050804000705 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months ended December 31, 2009. The Company reported a net loss of $15,276,000, or $0.33 per basic share, compared to a loss of $459,000, or $0.01 per basic share, for the three months ended December 31, 2008.
Celgene International Sàrl (NASDAQ: CELG) today announced results from a subset analysis of the international phase III trial (AZA-001) demonstrating that the overall survival benefit observed in higher-risk MDS patients extended to patients with acute myeloid leukemia (AML).
Scientists at the Gladstone Institutes and the University of California, San Francisco have successfully converted human skin cells into fully-functional pancreatic cells. The new cells produced insulin in response to changes in glucose levels, and, when transplanted into mice, the cells protected the animals from developing diabetes in a mouse model of the disease.
A study comparing the aerobic bacterial bioburden associated with surgical scrub attire shows significantly greater contamination among home-laundered attire than scrubs laundered by the healthcare facility, scrubs sent out by the facility to a third-party company for laundering, or single-use/disposable scrubs.
"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Muna Tosnim Alam, DO 8110 Maple Lawn Blvd Ste 235, Fulton, MD 20759-2694 Ph: (301) 340-8339 | Muna Tosnim Alam, DO 844 Washington Rd Ste 302, Westminster, MD 21157-6664 Ph: (410) 876-2003 |
News Archive
Aeolus Pharmaceuticals, Inc. announced today financial results for the three months ended December 31, 2009. The Company reported a net loss of $15,276,000, or $0.33 per basic share, compared to a loss of $459,000, or $0.01 per basic share, for the three months ended December 31, 2008.
Celgene International Sàrl (NASDAQ: CELG) today announced results from a subset analysis of the international phase III trial (AZA-001) demonstrating that the overall survival benefit observed in higher-risk MDS patients extended to patients with acute myeloid leukemia (AML).
Scientists at the Gladstone Institutes and the University of California, San Francisco have successfully converted human skin cells into fully-functional pancreatic cells. The new cells produced insulin in response to changes in glucose levels, and, when transplanted into mice, the cells protected the animals from developing diabetes in a mouse model of the disease.
A study comparing the aerobic bacterial bioburden associated with surgical scrub attire shows significantly greater contamination among home-laundered attire than scrubs laundered by the healthcare facility, scrubs sent out by the facility to a third-party company for laundering, or single-use/disposable scrubs.
"Now that we know how the body defends itself against the Chlamydia bacteria, we can develop a vaccine that optimises that defence. We have a basic understanding of how the vaccine could work, but some work remains to be done. We believe that it will take a few years before the vaccine becomes a reality," says researcher Ellen Marks, the author of the thesis.
› Verified 8 days ago
Eileen M Garavente, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 193 Stoner Avenue, Suite 300, Westminster, MD 21157 Phone: 410-876-3355 Fax: 410-876-3355 | |
Dr. Michael R Barnett, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 844 Washington Rd, Ste 302, Westminster, MD 21157 Phone: 410-848-6294 Fax: 410-848-3009 | |
Dr. Sushma Sidh, MD Obstetrics & Gynecology Medicare: May Accept Medicare Assignments Practice Location: 290 S Center St, Westminster, MD 21157 Phone: 410-876-4930 Fax: 410-857-4959 | |
Melvin Anthony Yeshnik, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 511 Jermor Ln, Suite 101, Westminster, MD 21157 Phone: 410-876-5400 Fax: 410-871-9917 | |
Christos Miltiades Ballas, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 844 Washington Rd, Suite 302, Westminster, MD 21157 Phone: 410-848-6294 | |
Dr. Emilynne B Buchanan, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 844 Washington Rd Ste 302, Westminster, MD 21157 Phone: 410-848-6294 Fax: 410-848-3009 | |
Candace Denise Norwood Wilson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 193 Stoner Avenue, Suite 300, Westminster, MD 21157 Phone: 410-876-3355 Fax: 410-876-3355 |